AI + MULTI-OMICS ➡ PRECISION ONCOLOGY
The Chiu Lab is an interdisciplinary team affiliate with the UPMC Hillman Cancer Center and Department of Medicine at the University of Pittsburgh. Our mission is to bridge cutting-edge computational algorithms to unmet needs in precision oncology. Read more about the PI.
Extending in vitro CRISPR screens to in vivo applications
Our latest Science Advances paper presents a novel “transfer learning” scheme that integrates cancer multi-omics and extends in vitro genetic screens to impracticable-to-screen tumors. The study was highlighted by @NCIgenomics as the #1 paper of 2021. Read the article.
AI-based in silico drug screening
Accurate prediction of cancer cells’ response to treatments is a key towards precision oncology. We developed an innovative, accurate AI model that virtually screens for ~300 anti-cancer drugs. Our study was selected as Springer Nature Research Highlights in Genetics of 2019 and has been cited for 150+ times within two years. Read the article.
2/2023. We will be presenting at San Antonio Pediatric Cancer Symposium @ San Antonio, TX.
1/2023. Dr. Chiu receives a pilot award from the UPMC Hillman Cancer Center Developmental Pilot Program with Dr. Yu-Chih Chen (MPI) to implement an intelligent drug screening device for single cancer cells.
12/2022. We will be presenting at AACR-JCA Joint Conference 2022 @ Maui, HI.
11/2022. Dr. Chiu is invited to present in the "BHI Technical and Educational Lecture" organized by the IEEE EMBS Community on Biomedical & Health Informatics (BHI).
9/2022. Dr. Chiu is selected as the "2022 Hillman Early Career Fellow for Innovative Cancer Research" by the Hillman Foundation.
8/2022. We will be presenting at ICIBM 2022 @ Philadelphia, PA. Dr. Chiu is co-chairing the session “Artificial Intelligence on Big Data: Promise for Early-stage Trainees.”
7/2022. We will be presenting at ISMB 2022 @ Madison, WI.